MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by Joyrideron Nov 07, 2019 9:53am

83 Views

Post# 30320705

RE:RE:RE:TAKE HIM AT HIS WORD ?

arichat24 wrote: And that the AGM meetings If I remember correctly he mentioned something about a new product and I thought he said it's like $2 million to do clinical trials and they basically don't have the money to do that I know there was at least one other person at the AGM who post on here so I don't know if they can confirm they remember that same information or not

I was the loudmouth at the meeting :-)

Yea, that's what he said and under repeted questioning (during and after the meeting) he said they had no plan in place yet on how to get the required funding. :-(

Bullboard Posts

Three micro-cap value stocks trading at peak pessimism